I doubt we will see a spin off of Lithium with interest in Lithium just gaining momentum. Also i think development of Goulamina would be greatly advantaged by the backing of the GOLD. I doubt there will be a spin off. I also would prefer retention of Goulamina.
Liked the discussion on page 10 on Downstream Scoping Study. Apart from Lithium Sulphate they also mentioned Lithium Hydroxide.
" Consideration of developing a refinery that produces Lithium hydroxide, which could then be
marketed directly to end users"
- Forums
- ASX - By Stock
- FFX
- Ann: Quarterly Activities Report
Ann: Quarterly Activities Report, page-39
-
- There are more pages in this discussion • 254 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online